These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 Junie. The technology gains life-saving medical insights by analysing human excrement. Die maatskappy het 'n reeks van drie patente ingedien wat elemente van sy mediese toiletsensor dek.

Three Toilets Detection Health Technologies

The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Europa, Japan en China.

A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, OutSense se tegnologie kan die bron van bloed langs die spysverteringskanaal identifiseer.

A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

Volgens OutSense se uitvoerende hoof, Yfat Scialom, who predicts that “met die ontploffing van digitale medisyne, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, inflammatoriese dermsiekte en urienweginfeksies.

Its solution consists of a multispectral optical sensor, 'n ligbron en 'n outonome siftingstoestel wat 'n WiFi-verbinding insluit. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.

OutSense has developed tools to diagnose abnormalities in human excreta. Inligting verkry uit bloedmonsters, gekombineer met bykomende ontleding van die tyd vanaf bloeding tot uitskeiding, verskaf besonderhede van die bloedingpatologie. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.

At the beginning of June, OutSense het aangekondig dat CommuniCare, 'n groot gesondheidsorg maatskappy met meer as 90 healthcare facilities in the US, sal vanjaar sy tegnologie begin loods. Benewens hierdie vlieënier, OutSense also plans to conduct clinical trials in Israel and Japan.

Besoek Meer Nuus by Viga.cc Nuus